VKTX – Viking Therapeutics, Inc.
Float Short %
24.45
Margin Of Safety %
Put/Call OI Ratio
0.23
EPS Next Q Diff
-0.15
EPS Last/This Y
-1.33
EPS This/Next Y
-0.65
Price
24.82
Target Price
93.93
Analyst Recom
1.12
Performance Q
-13.19
Relative Volume
0.68
Beta
0.65
Ticker: VKTX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | VKTX | 40.03 | 0.30 | 0.19 | 305371 |
| 2025-08-18 | VKTX | 42.13 | 0.23 | 0.43 | 232622 |
| 2025-08-19 | VKTX | 24.33 | 0.26 | 0.36 | 256618 |
| 2025-08-20 | VKTX | 25.73 | 0.31 | 0.30 | 306830 |
| 2025-08-21 | VKTX | 25.66 | 0.30 | 0.26 | 317153 |
| 2025-08-22 | VKTX | 26.03 | 0.29 | 0.23 | 320370 |
| 2025-08-25 | VKTX | 25.85 | 0.26 | 0.22 | 281065 |
| 2025-08-26 | VKTX | 25.9 | 0.26 | 0.24 | 293994 |
| 2025-08-27 | VKTX | 26.61 | 0.26 | 0.23 | 299952 |
| 2025-08-28 | VKTX | 27.59 | 0.26 | 0.30 | 302986 |
| 2025-08-29 | VKTX | 27.05 | 0.25 | 0.26 | 311173 |
| 2025-09-02 | VKTX | 27.48 | 0.24 | 0.22 | 277761 |
| 2025-09-03 | VKTX | 26.81 | 0.24 | 0.21 | 280465 |
| 2025-09-04 | VKTX | 26.55 | 0.24 | 0.16 | 285568 |
| 2025-09-05 | VKTX | 26.98 | 0.23 | 0.32 | 291819 |
| 2025-09-08 | VKTX | 25.49 | 0.23 | 0.17 | 271979 |
| 2025-09-09 | VKTX | 25.28 | 0.23 | 0.25 | 278985 |
| 2025-09-10 | VKTX | 25.8 | 0.24 | 0.12 | 282448 |
| 2025-09-11 | VKTX | 25.77 | 0.23 | 0.11 | 285299 |
| 2025-09-12 | VKTX | 24.81 | 0.23 | 0.22 | 287630 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | VKTX | 40.03 | -211.8 | -98.4 | -2.38 |
| 2025-08-18 | VKTX | 42.15 | -211.8 | -120.6 | -2.38 |
| 2025-08-19 | VKTX | 24.36 | -211.8 | 58.7 | -2.38 |
| 2025-08-20 | VKTX | 25.68 | -211.8 | -124.6 | -2.38 |
| 2025-08-21 | VKTX | 25.65 | -211.8 | -99.7 | -2.38 |
| 2025-08-22 | VKTX | 26.01 | -211.8 | -106.4 | -2.38 |
| 2025-08-25 | VKTX | 25.83 | -211.8 | -97.7 | -2.38 |
| 2025-08-26 | VKTX | 26.04 | -211.8 | -103.6 | -2.38 |
| 2025-08-27 | VKTX | 26.59 | -211.8 | -109.6 | -2.38 |
| 2025-08-28 | VKTX | 27.58 | -211.8 | -116.1 | -2.38 |
| 2025-08-29 | VKTX | 27.07 | -211.8 | -92.5 | -2.38 |
| 2025-09-02 | VKTX | 27.46 | -204.6 | -106.9 | -2.33 |
| 2025-09-03 | VKTX | 26.80 | -204.6 | - | -2.33 |
| 2025-09-04 | VKTX | 26.53 | -204.6 | - | -2.33 |
| 2025-09-05 | VKTX | 26.98 | -204.6 | - | -2.33 |
| 2025-09-08 | VKTX | 25.48 | -204.6 | - | -2.33 |
| 2025-09-09 | VKTX | 25.25 | -206.6 | - | -2.34 |
| 2025-09-10 | VKTX | 25.88 | -206.6 | - | -2.34 |
| 2025-09-11 | VKTX | 25.74 | -206.6 | - | -2.34 |
| 2025-09-12 | VKTX | 24.82 | -206.6 | - | -2.34 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | VKTX | -1.01 | -5.04 | 26.31 |
| 2025-08-18 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-19 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-20 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-21 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-22 | VKTX | -1.01 | -2.27 | 26.31 |
| 2025-08-25 | VKTX | -1.01 | -1.75 | 26.31 |
| 2025-08-26 | VKTX | -1.01 | -1.75 | 26.31 |
| 2025-08-27 | VKTX | -1.01 | -1.75 | 25.22 |
| 2025-08-28 | VKTX | -1.01 | -1.75 | 25.22 |
| 2025-08-29 | VKTX | -1.01 | -1.75 | 25.22 |
| 2025-09-02 | VKTX | -1.01 | -1.69 | 25.22 |
| 2025-09-03 | VKTX | -1.01 | -1.69 | 25.22 |
| 2025-09-04 | VKTX | -1.01 | -1.69 | 25.22 |
| 2025-09-05 | VKTX | -1.01 | -1.69 | 25.22 |
| 2025-09-08 | VKTX | -1.01 | -1.77 | 25.22 |
| 2025-09-09 | VKTX | -1.01 | -1.77 | 25.22 |
| 2025-09-10 | VKTX | -1.01 | -1.77 | 25.22 |
| 2025-09-11 | VKTX | -1.01 | -1.77 | 24.45 |
| 2025-09-12 | VKTX | -1.01 | -1.77 | 24.45 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.58
Avg. EPS Est. Current Quarter
-0.67
Avg. EPS Est. Next Quarter
-0.73
Insider Transactions
-1.01
Institutional Transactions
-1.77
Beta
0.65
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
11
Growth Score
18
Sentiment Score
12
Actual DrawDown %
75
Max Drawdown 5-Year %
-78.9
Target Price
93.93
P/E
Forward P/E
PEG
P/S
P/B
3.5
P/Free Cash Flow
EPS
-1.53
Average EPS Est. Cur. Y
-2.34
EPS Next Y. (Est.)
-2.99
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.68
Return on Equity vs Sector %
-46.4
Return on Equity vs Industry %
-33.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.05
EBIT Estimation
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 48
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading